YU
BHVN icon

Yale University’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Yale University’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,668
Closed -$1.13M – 22
2021
Q2 		$1.13M Hold
11,668
– – 0.39% 10
2021
Q1 		$798K Buy
+11,668
New +$944K 1.73% 6
2017
Q4 		– Sell
-250,000
Closed -$9.35M – 8
2017
Q3 		$9.35M Hold
250,000
– – 2.11% 5
2017
Q2 		$6.25M Buy
+250,000
New +$5.76M 1.52% 5

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yale University's BHVN Position: Q3 2021 in Review

Yale University sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2021, closing a stake of 11,668 shares — an estimated $1.13M sold.

Yale University first reported a position in BHVN in Q2 2017 and held it in 4 quarters. The position peaked at $9.35M in Q3 2017. 249 funds tracked by Wall St. Rank hold BHVN as of Q3 2021.

  • Yale University reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2021 after selling out during the quarter.
  • Yale University sold 11,668 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2021, an estimated $1.13M.
  • Yale University first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 4 quarters.
  • Yale University's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $9.35M in Q3 2017.
  • 249 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2021.

Based on Yale University's 13F filing for Q3 2021, filed 12 Nov 2021.